Accelerating MedTech Commercialisation
Discovery to Device bridges the gap between ideas and deployable products
Transforming ideas into products, to create real-world impact
Discovery to Device translates research into deployable medical technologies -through integrated prototyping, validation, and scale-up manufacturing.
We accelerate MedTech commercialisation by combining specialised infrastructure, industry-aligned expertise, ISO-accredited processes, and small-volume pilot manufacturing capability – enabling faster progression from concept to clinical and market readiness.
Capabilities
Device fabrication and functional materials
Fabrication of biosensors and advanced device components using precision materials engineering and thin-film technologies – enabling reliable performance, miniaturisation, and integration into clinical and wearable applications.
Prototyping and product assembly
End-to-end prototyping and assembly of medical devices, including micro-scale components, biocompatible materials, and rapid development of functional product enclosures ready for testing and iteration.
Biosensor development, validation and testing
Development and validation of biosensors through controlled biological testing, surface functionalisation, and performance characterisation -ensuring devices meet target sensitivity, reliability, and application requirements.
Electronics prototyping and low-volume pilot manufacturing
Rapid prototyping and small-batch production of flexible and integrated electronic systems within ISO 13485-aligned environments – supporting progression toward clinical validation and commercial deployment.
Madhu Bhaskaran
Director
Distinguished Professor Madhu Bhaskaran is an internationally recognised leader in functional materials and flexible electronics for medical devices. She leads Discovery to Device’s strategic direction – positioning the facility as a platform for translating cutting-edge research into scalable, industry-relevant technologies and sovereign manufacturing capability.